BNP Paribas Financial Markets Raises Stock Position in Amdocs Limited $DOX

Key Points

• BNP Paribas Financial Markets increased its Amdocs stake by 85.4% in the fourth quarter, bringing its holdings to 201,982 shares worth about $16.3 million.
• Amdocs shares were down 1.2% and recently traded near $60.09, close to their 52-week low of $59.40 and well below the $95.41 high.
• The company beat earnings expectations for the quarter with EPS of $1.78, and it also announced a quarterly dividend of $0.569 per share, implying a 3.8% annual yield.

BNP Paribas Financial Markets grew its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 85.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 201,982 shares of the technology company's stock after acquiring an additional 93,036 shares during the period. BNP Paribas Financial Markets owned about 0.19% of Amdocs worth $16,262,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC increased its stake in Amdocs by 82.6% during the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company's stock worth $969,100,000 after buying an additional 5,443,766 shares during the period. LSV Asset Management increased its stake in Amdocs by 0.8% during the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company's stock worth $296,159,000 after buying an additional 29,829 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company's stock worth $253,786,000 after buying an additional 54,676 shares during the period. Wellington Management Group LLP increased its stake in Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company's stock worth $258,583,000 after buying an additional 91,900 shares during the period. Finally, Vanguard Group Inc. increased its stake in Amdocs by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company's stock worth $251,602,000 after buying an additional 9,207 shares during the period. Hedge funds and other institutional investors own 92.02% of the company's stock.

Amdocs Trading Down 1.2%

NASDAQ DOX opened at $60.09 on Friday. Amdocs Limited has a one year low of $59.40 and a one year high of $95.41. The company has a 50-day simple moving average of $63.97 and a 200-day simple moving average of $71.39. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.98 and a current ratio of 0.98. The firm has a market capitalization of $6.49 billion, a PE ratio of 12.02, a price-to-earnings-growth ratio of 1.04 and a beta of 0.38.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 EPS for the quarter, beating the consensus estimate of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business had revenue of $1.17 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same period in the previous year, the business posted $1.78 EPS. The company's quarterly revenue was up 3.9% on a year-over-year basis. On average, equities analysts forecast that Amdocs Limited will post 6.56 earnings per share for the current year.

Amdocs Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Amdocs's payout ratio is presently 45.60%.

Amdocs News Roundup

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Zacks Research lifted its FY2026 EPS estimate to $6.60 from $6.56, suggesting slightly better near-term earnings potential. Amdocs estimate update
• Positive Sentiment: The firm also raised FY2027 EPS to $7.12 from $7.04 and FY2028 EPS to $7.69 from $7.55, indicating improving longer-term profit expectations. Amdocs estimate update
• Positive Sentiment: Quarterly estimates for Q4 2026, Q3 2027, Q4 2027, Q1 2028 and Q2 2028 were all nudged higher, which can reinforce optimism about Amdocs’ earnings trajectory. Amdocs estimate update
• Neutral Sentiment: Zacks kept its full-year consensus context broadly unchanged, with current-year EPS still expected at $6.54, so the revisions were incremental rather than dramatic. Amdocs estimate update
• Negative Sentiment: Near-term outlook was slightly softer for Q3 2026, with EPS cut to $1.67 from $1.68, and Q2 2027 was reduced to $1.70 from $1.73, which may have weighed on sentiment. Amdocs estimate update

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DOX shares. Cfra downgraded shares of Amdocs to a "sell" rating in a research note on Thursday, May 14th. Weiss Ratings reissued a "hold (c-)" rating on shares of Amdocs in a report on Friday, May 8th. Wall Street Zen lowered shares of Amdocs from a "buy" rating to a "hold" rating in a report on Saturday, May 16th. Finally, Stifel Nicolaus decreased their price objective on shares of Amdocs from $88.00 to $71.00 and set a "buy" rating for the company in a report on Thursday, May 14th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Amdocs has an average rating of "Hold" and a consensus price target of $86.67.

Amdocs Profile

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.